Anderson KJ, Ósvaldsdóttir ÁB, Atzinger B, Traustadóttir GÁ, Jensen KN, Lárusdóttir AE, Bergthórsson JT, Hardardóttir I, Magnúsdóttir E. The BLIMP1 - EZH2 Nexus in a Non-Hodgkin Lymphoma.
Oncogene. 2020 Jul;39(28):5138-5151.

 
 

Anderson K.A., Ósvaldsdóttir Á.B., Atzinger B., Traustadóttir G.Á., Jensen K.N., Lárusdóttir A.E., Bergþorsson J.Th., Harðardóttir I., Magnúsdóttir E.
The BLIMP1 - EZH2 Nexus in a Non-Hodgkin Lymphoma.
BioRxiv 2019 April

 
 

Magnúsdóttir E. Surani M.A.
How to make a primordial germ cell.
Development 2014 141 (2):245-252.

 
 

Gunesdogan U.,Magnúsdóttir E., Surani M.A.
Primordial germ cell specification: a context dependent cellular differentiation event.
Philos. Trans. R Soc. Lond. B. Biol. Sci. 2014 369(1657).

 
 

Kong, A., Thorleifsson, G., Frigge, M.L., Masson, G., Gudbjartsson, D.F., Villemoes, R., Magnúsdóttir, E., Olafsdottir, S.B., Thorsteinsdottir, U., and Stefansson, K.
Common and low-frequency variants associated with genome-wide recombination rate.
Nature Genetics 2014 (46):11–16.

 
 

Magnúsdóttir E., Dietmann S., Murakami K., Gunesdogan U., Tang F., Bao S., Diamanti E., Trotter M., Lao K., Gottgens B., Surani M.A.
A tripartite transcription factor network regulates primordial germ cell specification in mice.
Nature Cell Biology, 2013 15 (8):905-915.

 
 

Praetorius, C., Grill, C., Stacey, S.N., Metcalf, A.M., Gorkin, D.U., Robinson, K.C., Van Otterloo, E., Kim, R.S.Q., Bergsteinsdottir, K., Ogmundsdottir, M.H., Magnúsdóttir E. , Mishra P.J., Davis S.R., Guo T., Zaidi M.R., Helgason A.S., Sigurdsson M.I., Meltzer P.S., Merlino G., Petit V., Larue L., Loftus S.K., Adams D.R., Sobhiafshar U., Emre N.C.T., Pavan W.J., Cornell R., Smith A.G., McCallion A.S., Fisher D.E., Stefansson K., Sturm R.A., Steingrimsson E.
A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway.
Cell 2013 (155):1022–1033.

 
 

Grabole N., Tischler J., Leitch H.G., Hackett, J. Kim S., Tang F., Magnúsdóttir E. and Surani M.A.
Prdm14 promotes germline fate and naïve pluripotency by modulating signalling and the epigenome.
EMBO Reports, 2013 14(7):629-637.

 
 

Magnúsdóttir E., Gillich A., Grabole N., Surani M.A.
Combinatorial Control of Cell Fate and Reprogramming in the Mammalian Germ Line.
Curr. Opin. Genet. Dev. 2012 22(5):466-474.

 
 

Gillich A., Bao S., Hayashi K., Trotter M., Grabole N., Pasque V., Magnúsdóttir E., Surani M.A.
Epiblast Stem Cell-Based System Reveals Reprogramming Synergy of Germ Line Factors.
Cell Stem Cell, 2012 10(4):425-39.

 
 

Morgan M.A., Magnúsdóttir E., Kuo T.C., Tunyaplin C., Harper J., Arnold S.J., Calame K., Robertson E.J., Bikoff E.K.
Blimp-1/Prdm1 alternative promoter usage during mouse development and plasma cell differentiation.
Mol. Cell. Biol. 2009 (29):5813-27.

 
 

Martins G.A., Cimmino L., Liao J., Magnúsdóttir E., Calame K.
Blimp-1 directly represses il2 and the il2 activator fos, attenuating T cell proliferation and survival.
J. Exp. Med. 2008 (205):1959-65.

 
 

Cimmino L., Martins G.A., Liao J., Magnúsdóttir E., Grunig G., Perez K.R., Calame K. Blimp-1 attenuates Th1 differentiation by direct repression of ifng, tbx21 and bcl6 gene expression.
Journal of Immunology, 2008; (181):2338-2347.

 
 

Magnúsdóttir E., Kalachikov S., Mizukoshi K., Savitsky D., Ishida-Yamamoto A., Panteleyev A., Calame K.
Epidermal terminal differentiation depends on B lymphocyte-induced maturation protein-1.
PNAS 2007 (104): 14988-14993.

 
 

Martins G.A., Cimmino L., Shapiro-Shelef M., Szabolcs M., Herron A., Magnúsdóttir E., Calame K.
Transcriptional repressor Blimp-1 regulates T cell homeostasis and function.
Nature Immunology 2006 (5):457-65.